and ask your doctor if XDEMVY is right for you. Yuna Rapoport, M.D. is a paid spokesperson for Tarsus Pharmaceuticals, Inc. The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side effects in less than 2% of patients were chalazion/hordeolum and punctate keratitis. Please see additional important safety information at bit.ly/XDEMVY-ISI and full prescribing information at bit.ly/XDEMVY-PI and available at XDEMVY.com. XDEMVY (lotilaner ophthalmic solution) 0.25% is indicated for the treatment of Demodex blepharitis.”>
and ask your doctor if XDEMVY is right for you. Yuna Rapoport, M.D. is a paid spokesperson for Tarsus Pharmaceuticals, Inc. The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side effects in less than 2% of patients were chalazion/hordeolum and punctate keratitis. Please see additional important safety information at bit.ly/XDEMVY-ISI and full prescribing information at bit.ly/XDEMVY-PI and available at XDEMVY.com. XDEMVY (lotilaner ophthalmic solution) 0.25% is indicated for the treatment of Demodex blepharitis.”>
Watch CBS News
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.